cp wire

CP Wire Articles

Harpoon Therapeutics Begins Trial of Novel Immuno-Oncololgy Drug in Patients with Metastatic Castration-Resistant Prostate Cancer
  • Clinical data expected in 2019
  • HPN424 is designed as an ‘off-the-shelf’ T cell therapy
  • HPN424 serum half-life of 80 hours supporting once-weekly administration
... read more
Mon, 08/6/18 - 09:20 am
Summit’s Ridinilazole Preserved the Gut Microbiome of Patients with C. difficile in Ph II Trial
  • Ridinilazole treatment resulted in a 59% reduction in recurrence compared to vancomycin
  • C. difficile causes approximately 500,000 infections and 29,000 deaths in the US... read more
Fri, 08/3/18 - 10:03 am
Failed as a Cancer Treatment - Selumetinib Granted Orphan Designation in Europe for Neurofibromatosis Type 1
  • Selumetinib granted Orphan Status by the FDA in 2018
  • NF1 gene mutation occurs in approximately one in 3,000 births
  • Array Biopharma claims AZ owes approximately $192 million... read more
Fri, 08/3/18 - 09:23 am
The UK's MHRA Grants Early Access to Anlylam's Patisiran



Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced on 8/3/18 that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has... read more

Fri, 08/3/18 - 09:01 am
BrainScope Receives Prix Galien Award Nomination for Its Concussion and Traumatic Brain Injury Assessment Product

BrainScope today announced its second consecutive nomination for the 2018 Annual Prix Galien USA Awards for “Best Medical Technology” product. Its flagship BrainScope One product is a multi-modal... read more

Thu, 08/2/18 - 09:59 am

Pages